PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 5283959-1 1971 Previous studies have shown that the vitamin K-induced synthesis of prothrombin in a vitamin K-deficient rat is only slightly inhibited by cycloheximide treatment. Cycloheximide 139-152 coagulation factor II Rattus norvegicus 68-79 1661096-9 1991 The addition of cycloheximide to smooth muscle cells during their incubation with IL-1 beta completely inhibited smooth muscle cell nitrite production, the effects of the smooth muscle cells on platelet cGMP levels, and platelet responses to thrombin. Cycloheximide 16-29 coagulation factor II Rattus norvegicus 242-250 5437347-0 1970 Reversal by vitamin K of cycloheximide inhibited biosynthesis of prothrombin in the isolated perfused rat liver. Cycloheximide 25-38 coagulation factor II Rattus norvegicus 65-76 15281096-9 2004 Pre-treatment of smooth muscle cells with cycloheximide abolished the reduction of PN-1 expression by thrombin. Cycloheximide 42-55 coagulation factor II Rattus norvegicus 102-110 9182610-6 1997 The thrombin-mediated increase in NGF secretion was prevented by actinomycin D and cycloheximide, suggesting that RNA transcription and protein synthesis are required. Cycloheximide 83-96 coagulation factor II Rattus norvegicus 4-12 5283959-3 1971 When cycloheximide (5 mg/kg) was given to vitamin K-deficient rats 30 min before vitamin K, about 70% of the amount of prothrombin seen in rats not treated with cycloheximide was produced (two-stage assay), and the prothrombin band could be seen on the electrophoretic gels. Cycloheximide 5-18 coagulation factor II Rattus norvegicus 119-130 5283959-3 1971 When cycloheximide (5 mg/kg) was given to vitamin K-deficient rats 30 min before vitamin K, about 70% of the amount of prothrombin seen in rats not treated with cycloheximide was produced (two-stage assay), and the prothrombin band could be seen on the electrophoretic gels. Cycloheximide 5-18 coagulation factor II Rattus norvegicus 215-226 5283959-4 1971 However, if radioactive amino acids are administered to the rats after cycloheximide treatment, the newly formed prothrombin contains no radioactivity. Cycloheximide 71-84 coagulation factor II Rattus norvegicus 113-124 5283959-5 1971 The isolated prothrombin does contain radioactivity if the vitamin K-deficient rats are treated with vitamin K but no cycloheximide. Cycloheximide 118-131 coagulation factor II Rattus norvegicus 13-24 19878520-6 2010 Thrombin (2.5 U/mL) induced an increase in immunoreactive ET-1 expression, which was inhibited by cycloheximide (10 microg/mL), and an increase in preproET-1 mRNA expression, as assessed by reverse transcription polymerase chain reaction. Cycloheximide 98-111 coagulation factor II Rattus norvegicus 0-8 17498698-5 2007 Intracerebroventricular injection of argatroban or cycloheximide, both of which prevent thrombin cytotoxicity in vitro, exhibited a significant neuroprotective effect against ICH-induced injury. Cycloheximide 51-64 coagulation factor II Rattus norvegicus 88-96